(Q44642220)

4 December 2017

title

Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure (English)

1 reference

4 December 2017

1 reference

chronic heart failure

1 reference

Claudio Ceconi

4

0 references

Pietro Guida

5

object named as

Pietro Guida

1 reference

4 December 2017

author name string

Elisabetta De Tommasi

1

1 reference

4 December 2017

Massimo Iacoviello

2

1 reference

4 December 2017

Roberta Romito

3

1 reference

4 December 2017

Francesco Massari

6

1 reference

4 December 2017

Gloria Francolini

7

1 reference

4 December 2017

Federico Bertocchi

8

1 reference

4 December 2017

Roberto Ferrari

9

1 reference

4 December 2017

Paolo Rizzon

10

1 reference

4 December 2017

Maria Vittoria Pitzalis

11

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

4 December 2017

published in

American Heart Journal

1 reference

4 December 2017

volume

146

1 reference

4 December 2017

issue

5

1 reference

4 December 2017

page(s)

E17

1 reference

Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart).

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Angiotensin II and sympathoactivation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Angiotensin peptides and baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Evidence that the area postrema mediates the central cardiovascular response to angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Aldosterone blunts the baroreflex response in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Anti-adrenergic effects of angiotensin converting enzyme inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Comparison between noninvasive indices of baroreceptor sensitivity and the phenylephrine method in post-myocardial infarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effects of enalapril on heart rate variability in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effect of quinapril on blood pressure and heart rate in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Noradrenaline, atrial natriuretic peptide, bombesin and neurotensin in myocardium and blood of rats in congestive cardiac failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

ACE inhibition improves vagal reactivity in patients with heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effects of angiotensin II (AT1) receptor blockade on cardiac vagal control in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effects of losartan treatment on cardiac autonomic control during volume loading in patients with DCM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. SOLVD Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Sympathetic responsiveness and plasma norepinephrine during therapy of chronic congestive heart failure with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Augmented short- and long-term hemodynamic and hormonal effects of an angiotensin receptor blocker added to angiotensin converting enzyme inhibitor therapy in patients with heart failure. Vasodilator Heart Failure Trial (V-HeFT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2803%2900366-1

10.1016/S0002-8703(03)00366-1

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference